John H. Vaughan

John H. Vaughan's AcademicInfluence.com Rankings

John H. Vaughan

Biology

#6436

World Rank

#9147

Historical Rank

Immunology

#332

World Rank

#345

Historical Rank

biology Degrees

Download Badge

Biology

John H. Vaughan's Degrees

PhD Immunology Stanford University

Why Is John H. Vaughan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John H. Vaughan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of neuropeptides on production of inflammatory cytokines by human monocytes (1988) (577)
In vitro Cell Migration as a Model for Delayed Hypersensitivity.∗ (1962) (521)
Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. (1989) (516)
Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. (1987) (447)
Effect of neuropeptides on production of inflammatory cytokines by human monocytes. (1989) (389)
Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. (1986) (221)
Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. (1982) (216)
In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects (1978) (215)
Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. (1984) (194)
Procainamide-induced lupus erythematosus. Clinical and laboratory observations. (1972) (181)
Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. (1977) (164)
Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG. (1977) (129)
Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. (1982) (128)
Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. (1983) (127)
Autoantibodies and the spectrum of Sjögren's syndrome. (1979) (126)
Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes. (1985) (126)
The Epstein‐Barr Virus Glycoprotein gp110, a Molecular Link between HLA DR4, HLA DR1, and Rheumatoid Arthritis (1988) (111)
Antinuclear antibody induced by procainamide. A prospective study. (1969) (109)
Complement fixation by rheumatoid factor. (1975) (107)
Use of Anti-Rh Sera for Demonstrating Agglutination Activating Factor in Rheumatoid Arthritis.∗ (1956) (106)
Regulation of Epstein‐Barr virus infection by recombinant interferons. Selected sensitivity to interferon‐γ (1985) (102)
Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. (1979) (101)
Genetic influence on the levels of circulating CD5 B lymphocytes. (1987) (96)
Altered lymphocyte reactivity in rheumatoid arthritis. (1976) (95)
The distribution of serum immunoglobulins, anti-gamma-G globulins ("rheumatoid factors") and antinuclear antibodies in White and Negro subjects in Evans County, Georgia. (1967) (94)
The detection of cell-bound antibody on complement-coated human red cells. (1970) (94)
GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA. (1964) (89)
Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies. (1986) (86)
Phytohemagglutinin binds to the 20‐kDa molecule of the T3 complex (1985) (85)
Rheumatoid factor-producing cells detected by direct hemolytic plaque assay. (1976) (84)
Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes. (1978) (80)
Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases. (1968) (80)
Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. (1986) (79)
Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. (1985) (77)
BENIGN HYPERGAMMAGLOBULINEMIC PURPURA OF WALDENSTRÖM (1971) (74)
The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone therapy in lupus erythematosus disseminatus. (1951) (71)
Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. (1983) (71)
Modified diphenylamine reaction for increased sensitivity. (1972) (70)
Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen (1987) (70)
Immunologic reactions of bronchial tissues in asthma. (1971) (70)
Serum responses in rheumatoid arthritis. (1959) (68)
Delineation of a cross-reactive idiotype on human autoantibodies with antibody against a synthetic peptide (1984) (68)
Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step. (1982) (67)
Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. (1986) (67)
Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. (1982) (64)
Isolation of human PMN leukocytes and granules: observations on early blood diluion and on heparin. (1968) (64)
Transfusion studies in rheumatoid arthritis. (1961) (61)
Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells. (1980) (61)
Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. (1995) (61)
ANTINUCLEAR FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS. (1965) (61)
Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4. (1980) (60)
Provoking factors in bronchial asthma. (1975) (59)
Transtracheal aspiration studies in asthmatic patients in relapse with "infective" asthma and in subjects without respiratory disease. (1975) (59)
Inheritance of immunoglobulin M rheumatoid-factor idiotypes. (1980) (59)
Light and heavy chain components of gamma globulins in urines of normal persons and patients with agammaglobulinemia. (1967) (58)
Anti-hypervariable region antibody induced by a defined peptide: an approach for studying the structural correlates of idiotypes. (1984) (57)
Characterization of human rheumatoid factors with seven antiidiotypes induced by synthetic hypervariable region peptides (1985) (57)
Behavior of the rheumatoid arthritis agglutinating factor with immune precipitates. (1956) (56)
IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome. (1979) (56)
The majority of human monoclonal IgM rheumatoid factors express a "primary structure-dependent" cross-reactive idiotype. (1985) (56)
Age-associated changes in Epstein-Barr virus-induced human lymphocyte autoantibody responses. (1981) (55)
Potassium iodide sensitivity in four patients with hypocomplementemic vasculitis. (1979) (55)
Metabolism of C4 and factor B in rheumatoid arthritis. Relation to rheumatoid factor. (1980) (52)
Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis. (1986) (52)
Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection. (1980) (51)
SERUM COMPLEMENT IN RHEUMATOID ARTHRITIS* (1951) (50)
The effect of 5-bromouracil deoxyriboside on the synthesis of antibody in vitro. (1960) (50)
Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. (1995) (50)
Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. (2000) (48)
The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1). (1987) (48)
Purpura, arthralgia, and IgM-IgM cryoglobulinemia with rheumatoid factor acrivity. Response to cyclophosphamide and splenectomy. (1971) (48)
1992 Joseph J. Bunim Lecture. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. (1993) (48)
Autoantibodies to human heat shock protein (hsp)60 may be induced by Escherichia coli groEL (1996) (48)
Plasma complement changes during bronchospasm provoked in asthmatic patients * (1977) (47)
Immunoglobulin E-rheumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases. (1981) (46)
Major Histocompatibility Complex Class II-dependent Unfolding, Transport, and Degradation of Endogenous Proteins* (1997) (46)
The significance of antinuclear factors in rheumatoid arthritis. (1965) (45)
The role of the T3 molecular complex in antigen recognition and subsequent activation events. (1984) (45)
Anti DNA antibody production by lymphoid cells of NZB-W mice and human systemic lupus erythematosus (SLE). (1973) (45)
Antinuclear antibodies following hydralazine toxicity. (1967) (45)
Kawasaki disease in healthy young adult. (1980) (44)
T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells. (1981) (44)
Quantitative considerations of the rheumatoid factor. (1958) (43)
Canine immunoglobulins. I. Evidence for six immunoglobulin classes. (1967) (43)
Search for infectious agents in rheumatoid arthritis. (1966) (42)
Inhibition of Rapid Production of Antibody by Cortisone. Study of Secondary Response.∗ (1952) (42)
Current status of the rheumatoid factor. (1962) (40)
A study of antibody production in vitro. (1960) (40)
Propranolol and the treatment of rheumatoid arthritis. (1980) (40)
THE REACTION OF RHEUMATOID FACTOR WITH ANIMAL GAMMA-GLOBULINS: QUANTITATIVE CONSIDERATIONS. (1965) (39)
Cellular requirements for pokeweed mitogen-induced autoantibody production rheumatoid arthritis. (1980) (39)
A biochemical and electron microscopy study of rice bodies from rheumatoid patients. (1965) (38)
Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. (1990) (38)
Dissection of the mechanisms of immune injury in rheumatoid arthritis, using total lymphoid irradiation. (1988) (37)
Two different rheumatoid factor-producing cell populations distinguished by the mouse erythrocyte receptor and responsiveness to polyclonal B cell activators. (1983) (37)
Relative reactivities of rheumatoid factors in serum and cells. Evidence for a selective deficiency in serum rheumatoid factor. (1978) (34)
IMMUNOLOGIC RESPONSIVENESS OF MAN TO PENICILLIN. (1962) (34)
1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. (1986) (34)
Hypersensitivity to histamine and systemic anaphylaxis in mice with pharmacologic beta adrenergic blockade: protection by nucleotides. (1976) (33)
Relation of agammaglobulinemia sera to rheumatoid agglutination reactions. (1958) (33)
Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma. (1981) (33)
Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. (1990) (32)
An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway (1996) (31)
Hemagglutination by Rheumatoid Factor of Cells Coated with Animal Gamma Globulins.∗ (1964) (31)
Effect of therapeutic dosages of prednisone on human immunoglobulin G metabolism. (1972) (31)
Immunoglobulins G, A, and M in systemic lupus erythematosus. Relationship to serum complement titer, latex titer, antinuclear antibody, and manifestations of clinical disease. (1968) (30)
Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein Barr virus DNA probes. (1986) (30)
Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody. (1982) (30)
Extraction and partial purification of the histamine-sensitizing factor of Bordetella pertussis. (1974) (30)
Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph. (1984) (29)
Immunoglobulins in bronchial tissues from patients with asthma, with special reference to immunoglobulin E (1971) (29)
Characterization of an IgA rheumatoid factor: finding properties and reactivity with the subclasses of human G globulin. (1972) (29)
Autosensitivity diseases. Immunologic and pathogenetic concepts in lupus erythematosus, rheumatoid arthritis and hemolytic anemia. (1966) (29)
Selective induction of autoantibody secretion in human bone marrow by Epstein Barr virus. (1982) (28)
DYSGAMMAGLOBULINEMIA IN THE PRESENCE OF PLASMA CELLS. (1965) (28)
Relation of intracytoplasmic inclusions in joint fluid leukocytes to anti-γG globulins (1968) (28)
ANTINUCLEAR ANTIBODIES IN RABBIT ANTISERA (1966) (27)
SERUM SICKNESS AND PLASMACYTOSIS. A CLINICAL, IMMUNOLOGIC AND HEMATOLOGIC ANALYSIS. (1963) (26)
Potential role of Epstein-Barr virus in Sjögren's syndrome. (1987) (26)
Modulation of human rheumatoid factor-specific lymphocyte responses with a cross-reactive anti-idiotype bearing the internal image of antigen. (1984) (25)
Identical igm antibodies recognizing a glycine‐alanine epitope are induced during acute infection with epstein‐barr virus and cytomegalovirus (1990) (25)
The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Barr virus and which may be a heterogeneous nuclear ribonucleoprotein. (1997) (25)
STUDIES ON THE ANTIBODIES IN RABBIT ANTISERA RESPONSIBLE FOR SENSITIZATION OF HUMAN SKIN (1953) (23)
Immunologic and biochemical properties of the histamine-sensitizing factor from Bordetella pertussis. (1975) (23)
Multicenter comparison of naproxen and indomethacin in rheumatoid arthritis. (1978) (22)
Different populations of rheumatoid factor idiotypes induced by two polyclonal B cell activators, pokeweed mitogen and Epstein--Barr virus. (1981) (22)
Epstein-Barr virus in rheumatoid arthritis. (1985) (22)
CALCINOSIS UNIVERSALIS COMPLICATING DERMATOMYOSITIS. ITS TREATMENT WITH NA2 EDTA. REPORT OF TWO CASES IN CHILDREN. (1964) (22)
Antibody formation in dysgammaglobulinemia. (1966) (22)
Serum sickness. Evidence in man of antigen-antibody complexes and free light chains in the circulation during the acute reaction. (1967) (22)
The Epstein-Barr virus in autoimmunity (2004) (22)
Immune system in rheumatoid arthritis: possible implications in neoplasms. (1985) (21)
Failure of lymphocyte transformation in response to gamma-globulins in rheumatoid arthritis. (1969) (21)
Immunoglobulin G subclasses of antinuclear antibodies and renal deposits. Comparison of systemic lupus erythematosus, drug-induced lupus and rheumatoid arthritis. (1971) (21)
A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis. (1986) (21)
IgM rheumatoid factor autoantibody and immunoglobulin-producing precursor cells in the bone marrow of humans. (1985) (21)
A study of gamma globulin in rheumatoid arthritis. (1955) (20)
Structural similarities in the kappa light chains of human rheumatoid factor paraproteins and serum immunoglobulins bearing a cross-reactive idiotype. (1985) (20)
The unitary nature of "complete" and "incomplete" pathologic cold hemagglutinins. (1962) (20)
Immunologic reactions to penicillin. (1961) (20)
The Role of Complement in the Lysis of Leucocytes by Tuberculo-protein.∗ (1949) (20)
Thoracic duct drainage in rheumatoid arthritis. (1984) (19)
Lymphocyte function in rheumatic disorders. (1975) (19)
The immune response to Epstein-Barr nuclear antigen: conformational and structural features of antibody binding to synthetic peptides. (1984) (19)
Metabolism of autologous and homologous IgG in rheumatoid arthritis. (1977) (19)
Activation of the alternative complement pathway in systemic lupus erythematosus. (1976) (19)
Canine immunoglobulins. II. Antibody activities in six immunoglobulin classes. (1967) (18)
Heterogeneity of Antinuclear Factors in Lupus Erythematosus and Rheumatoid Arthritis.∗ (1965) (18)
Partition of the skin-sensitizing antibody among alcohol-fractionated plasma proteins. (1952) (17)
Physiology and pathology of rheumatoid factors (2005) (17)
Effects of recombinant human interferons on rheumatoid arthritis B lymphocytes activated by Epstein-Barr virus. (1987) (17)
Studies on urinary γ-globulins in patients with rheumatoid arthritis (1966) (17)
Lymphocyte mitogenesis induced by monoclonal antibodies to the T3 complex. Differential modulation by human IgG. (1984) (17)
Synthetic peptide derived from the epstein‐barr virus encoded early diffuse antigen (ea‐d) reactive with human antibodies (1987) (16)
Fractionation of human lymphocyte subpopulations on immunoglobulin coated Petri dishes. (1981) (16)
Immunologic features of erythrocyte sensitization. I. Acquired hemolytic disease. (1956) (16)
Frequencies of Epstein-Barr virus-inducible IgM anti-IgG B lymphocytes in normal children and children with juvenile rheumatoid arthritis. (1982) (16)
Solid-phase selection of human T lymphocyte subpopulations using monoclonal antibodies. (1981) (16)
Association of rheumatoid factor with complement activation in rheumatoid arthritis and other diseases. (1983) (16)
A comparison of naproxen, indomethacin and aspirin in osteoarthritis. (1980) (16)
Molecular interactions in human T-cell-mediated cytotoxicity to Epstein-Barr virus. I. Blocking of effector cell function by monoclonal antibody OKT3. (1982) (15)
Immunochemical Studies on Equine Antibodies to Human γ2-Globulin (1965) (15)
Cromolyn treatment of asthma. Trials in corticosteroid-dependent asthmatics. (1971) (15)
Gamma globulin complexes in rheumatoid arthritis and hypergammaglobulinemic purpura. (1974) (15)
Platelet aggregation in asthmatic and normal subjects. (1974) (15)
An unidentified antibody in anti-egg albumin sera revealed by the agar diffusion technic; methods for its immunochemical analysis. (1954) (15)
T cell proliferation induced by anti‐cd3 antibodies: requirement for a t‐t cell interaction (1988) (15)
Rheumatoid arthritis, 1970-1972. (1973) (15)
Complement activation by antibodies to Sm in systemic lupus erythematosus. (1983) (15)
Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients. (1982) (14)
Anti-DNA plaque-forming cells (PFC) and rosette-forming cells (RFC) in spleens of NZB-WF female (B-W) mice. (1972) (14)
Effect of 17-Hydroxy-11-Dehydrocorticosterone and Adrenocorticotropic Hormone upon Plasma Gamma Globulin, Fibrinogen, and Erythrocyte Sedimentation Rate.∗ (1951) (14)
Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes. (1983) (14)
The Epstein-Barr virus and systemic lupus erythematosus. (1997) (14)
Clinical profiles of bronchial asthma. (1973) (13)
Immunologic features of erythrocyte sensitization. II. The nature of blood group antibodies. (1957) (13)
Metabolism of factor B of serum complement in rheumatoid arthritis. (1978) (13)
Septic sternoclavicular arthritis with Pasteurella multocida and Streptococcus sanguis. (1982) (13)
Histamine hypersensitivity in mice induced by Bordetella pertussis or pharmacologic beta adrenergic blockade. Effects of adrenergic, cholinergic, and other drugs. (1976) (12)
Correlation between anti-RANA and anti-EBNA titers in normal subjects with and without HLA-DRw4. (1980) (12)
ENHANCEMENT OF PRODUCTION IN VITRO BY IgG AND ANTIGEN-ANTIBODY COMPLEXES (1977) (12)
Leukoplasmapheresis for myasthenia gravis. Acetylcholine receptor antibody production. (1982) (12)
Failure of immunocytoadherence to demonstrate delayed hypersensitivity. (1971) (12)
Waldenström's macroglobulinemia with increased serum IgG levels treated with low doses of cyclophosphamide. (1969) (12)
Interleukin‐6 (IL‐6) and Joint Tissues (1989) (12)
CLINICAL CORRELATIONS OF THE DIRECT ANTIGLOBULIN REACTION * (1965) (11)
Origin and age-associated changes in the expression of a physiologic autoantibody. (1985) (11)
Selective lymphocyte deficiency in seronegative rheumatoid arthritis. (1981) (11)
Rheumatologic disorders due to immune complexes. (1973) (10)
Phosphate metabolism of spleen cells in antibody formation. (1960) (10)
Purification of recombinant human Hsp60: use of a GroEL-free preparation to assess autoimmunity in rheumatoid arthritis. (1995) (10)
Methacholine challenge and the diagnosis of bronchial asthma (1973) (10)
A study of rubella haemagglutination inhibition antibodies in rheumatoid arthritis. (1970) (10)
Effect of iron dextran, gold thiosulphate, and hydrocortisone acetate on experimental synovitis in the guinea pig. (1971) (10)
Properties of mouse homocytotropic and heterocytotropic antibodies. (1976) (10)
Changes in the expression of two Epstein‐Barr virus‐associated antigens, EBNA and RANA, during the cell cycle of transformed human B lymphoblasts (1980) (9)
Observations on the nature of the antigen in tanned red cell hemagglutination. (1962) (9)
Adjuvant activity of the histamine-sensitizing factor of Bordetella pertussis in different strains of mice. (1975) (9)
Secondary amyloidosis and sicca syndrome. (1980) (9)
Auto-immune diseases. General considerations. (1966) (9)
The common occurrence of internal image type anti-idiotypic antibodies in rabbits immunized with monoclonal and polyclonal human IgM rheumatoid factors. (1986) (9)
Eosinophiles in Passive Anaphylaxis.∗ (1955) (8)
Studies with human leukocyte lysosomes. Evidence for antilysosome antibodies in lupus erythematosus and for the presence of lysosomal antigen in inflammatory diseases. (1975) (8)
Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1. (1986) (8)
Immunosuppressive drugs in rheumatoid arthritis. (1969) (8)
The effect of ACTH on blood complement, gamma globulins, and fibrinogen. (1950) (8)
Human T cell responses to the Epstein-Barr nuclear antigen-1 (EBNA-1) as evaluated by synthetic peptides. (1989) (8)
Polymorphism of the EBNA/RANA antigen in Epstein-Barr virus-positive cell lines. (1984) (8)
Structural and functional characteristics of the CD3 (T3) molecular complex on human thymocytes. (1987) (8)
Discordant expression of 2 Epstein-Barr virus-associated antigens, EBNA and RANA, in man-rodent somatic cell hybrids. (1981) (7)
Differential effects of propranolol on lymphocyte rosette formation and response to plant mitogens. (1978) (7)
Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus (1989) (7)
Occurrence of two germline‐related rheumatoid factor idiotypes in rheumatoid arthritis and in non‐rheumatoid seropositive individuals (1990) (7)
Drugs affecting the release of rheumatoid factor in a plaque-forming cell assay. (1978) (7)
Expression of a germline human kappa chain-associated cross-reactive idiotype after in vitro and in vivo infection with Epstein-Barr virus. (1987) (6)
The rheumatoid factor activity of dextran eluates of erythrocytes and platelets. (1963) (6)
Prolonged thoracic-duct drainage in rheumatoid arthritis and systemic lupus erythematosus. (1979) (6)
Hypersensitivity in the rheumatic diseases. (1961) (6)
Hypersensitivity mechanisms in rheumatoid arthritis (1959) (6)
RELATION OF RHEUMATOID FACTOR TO INTRACELLULAR INCLUSIONS * (1969) (6)
Studies on the antibodies in rabbit antisera responsible for sensitization of human skin. II. Characteristics of antisera to egg white and to conalbumin. (1954) (6)
Viruses and autoimmune disease. (1996) (6)
Toxic shock syndrome or Kawasaki disease. (1981) (6)
Frentizole therapy in systemic lupus erythematosus. (1980) (5)
Problems in the corticosteroid therapy of rheumatic disease. (1959) (5)
Transcricothyroid cultures in “infectious” asthma (1973) (5)
Rheumatoid factors in human autoimmune disease: their origin, development and function. (1986) (5)
IgArheumatoid factor intheseraandsaliva of patients withrheumatoid arthritis andSjogren's syndrome (1979) (5)
CHAPTER 1 – Bronchial Asthma: Pathophysiology* (1973) (5)
SPECIFICITY OF RHEUMATOID FACTOR WITH GAMMA GLOBULIN OF DIFFERENT SPECIES. (1963) (5)
Effects of monoclonal antibodies against lymphocyte surface antigens on interleukin 2 excretion by Epstein-Barr virus-specific human T-cell hybridomas. (1984) (5)
Auto-Sensitization of Trypsin Treated Human Red Cells by Complement.∗ (1964) (5)
Effect of an anabolic agent (nilevar) on nitrogen and mineral metabolism in two patients with rheumatoid disease. (1960) (5)
The Relationship Between L-Chain Synthesis and γ-Globulin Production (1973) (4)
Release of lymphokines following Epstein-Barr virus infection in vitro of blood lymphocytes from patients with autoimmune diseases. (1986) (4)
Antibodies to Epstein-Barr virus associated antigens in Pima Indians with and without rheumatoid arthritis (2004) (4)
Effect of levamisole on pokeweed mitogen stimulation of immunoglobulin production in vitro. (1981) (4)
Age-related restriction of the light chain heterogeneity of anti-IgG antibodies induced by Epstein-Barr virus stimulation of human lymphocytes in vitro. (1981) (4)
The mosaic of autoimmunity: by Y. Shoenfeld and D. Isenberg, Elsevier Science Publishers, 1989. Dfl 285.00 ISBN 0 444 81184 2 (1990) (4)
The role of the T3 molecular complex on human T lymphocyte-mediated cytotoxicity. (1985) (4)
Presidential address: Allergy: Current crisis (1968) (3)
The incidence of anti-RANA in Mexican Mestizo populations with rheumatoid arthritis or other conditions. (1983) (3)
ANTINUCLEAR FACTORS IN RHEUMATOID ARTHRITIS * (1965) (3)
Interleukins and Interferons during EBV Infection (1987) (3)
Rheumatoid arthritis: evidence for a defect in T-cell function. (1984) (3)
A Comparison of EA‐Rosette Formation on Lymphocytes Using Rabbit and Human Sensitizing Antibodies (1981) (3)
Articular scanning and external counting in experimental synovitis in the guinea-pig. (1971) (3)
Relation of intracytoplasmic inclusions in joint fluid leukocytes to anti-gamma-G globulins. (1968) (3)
Gamma 2 , GammalA , and GammalM Antinuclear Factors in HumanSera * (2)
Metabolic inhibition of plaque-forming cells: comparison of human rheumatoid-factor-producing cells with mouse anti-sheep erythrocyte-producing cells. (1979) (2)
Rheumatoid factors and their biological significance. Summary. (1969) (2)
Induction and yield of reaginic antibodies in mouse serum and ascitic fluid. (1976) (2)
Dunlop-Dottridge lecture. Rehumatoid arthritis, rheumatoid factor and the Epstein-Barr virus. (1979) (2)
Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine. (1986) (2)
Serum and Urinary Gamma Globulins in Rheumatoid Arthritis (1966) (2)
Immunochemical studies on equine antibodies to human gamma-2-globulin. (1965) (2)
Infection and rheumatic diseases: a review (2). (1990) (2)
CHAPTER II MEDICAL SPECIALTY TRAINING Rheumatology's Role in the Gener l Training of the Internist (1968) (2)
The protective effects of nucleotides on the histamine hypersensitivity of Bordetella pertussis-treated mice. (1974) (2)
Autosensitivity diseases (concluded). Immunologic and pathogenetic concepts in lupus erythematosus, rheumatoid arthritis and hemolytic anemia. (1966) (1)
Gamma2, GammalA, and GammalM Antinuclear Factors in Human Sera * (1)
Clinical immunology. Introduction. (1973) (1)
Treatment of infected tonsils and adenoids. (1949) (1)
The emerging concept of clinical immunology. (1972) (1)
Variability in generation of anti-sheep erythrocyte plaque-forming cells from cultures of human peripheral blood. Influence of monocytes. (1980) (1)
Rheumatology's role in the general training of the internist. (1968) (1)
Allergy: current crisis. (1968) (1)
Thecommonoccurrence ofinternal imagetypeanti-idiotypic antibodies inrabbits immunized withmonoclonal and polyclonal humanIgMrheumatoid factors (1986) (1)
EBV, molecular mimicry and rheumatoid arthritis: a hypothesis (1989) (1)
Characterization of Epstein-Barr virus-specific T-cell hybridomas derived from infectious mononucleosis. (1985) (1)
Gastric volvulus and Felty's syndrome. (1980) (1)
Autoantibody Generation during Infectious Mononucleosis (1987) (1)
Infection and rheumatic diseases: a review (Part 1 of 2). (1989) (1)
Analysis of Peripheral Blood and Salivary Gland Lymphocytes in Sjogren’s Syndrome (1983) (0)
STUDIES ON THE ANTIBODIES IN RABBIT ANTISERA RESPON- SIBLE FOR SENSITIZATION OF HUMAN SKIN I. THE ROLE OF IMPURITIES IN CRYSTALLINE EGG ALBUMIN IN STIMULATING THE PRODUCTION OF SKIN-SENSITIZING ANTIBODY* (2003) (0)
The effects of nucleotides on histamine hypersensitivity of pertussis-treated mice (1973) (0)
Radiation treatment of infected or hypertrophied lymphoid tissue in the throat and nasopharynx. (1947) (0)
Certification in allergy. (1967) (0)
Cromolyn Sodium Trial in Perennial Asthmatics. (1970) (0)
Contents, Vol. 49, 1975 (1975) (0)
CELLULAR ASPECTS OF THE IM\MUNOLOGY OF RHEUMIATOID ARTHRITIS (2008) (0)
In vitro methods in cell-mediated immunity: Bloom, Barry R., and Glade, Philip R. (Eds.) Academic Press, New York, 1971, $14.00. 578 pp (1972) (0)
Systemic lupus erythematosus an increasing problem; a clinical survey of 35 cases. (1958) (0)
Autoimmune Diseases: Drugs, Viruses, and Mechanisms. (1972) (0)
Comment on preceding article (1963) (0)
Assay of anti-Epstein-Barr virus nuclear antigen antibodies with synthetic polypeptides (1990) (0)
Indications for Irradiation in Intra-uterine Bleeding1 (1933) (0)
Recent developments in rheumatoid arthritis and related diseases (1962) (0)
Taking steady aim. (1971) (0)
Precarious man: autoallergic diseases. (1969) (0)
Agglutination by rheumatoid sera of red cells coated with non-agglutinating anti-D antibody. (1958) (0)
The relationship between L-chain synthesis and gamma-globulin production. (1973) (0)
SUMMARY (1969) (0)
TEXTBOOK OF IMMUNOPATHOLOGY (1970) (0)
RHEUMATIC DISEASES IN THE USSR. (1965) (0)
Purpura, Arthralgia, and IgM-IgG Cryoglobulinemia with Rheumatoid Factor Activity (2020) (0)
Propreties of mouse homocytotropic and hetrocytotropic antibodies. (1976) (0)
The Immune Response to Glycine-Rich Sequences of Epstein-Barr Nuclear Antigen-1 (EBNA-1) in Autoimmunity: B and T Cell Epitopes (1989) (0)
Inhibition by Bordetella pertussis extract (Bpe) of tritiated thymidine uptake (TTU) in stimulated human lymphocytes (1973) (0)
On the Miology of Rheumatoid Arthritis (1988) (0)
Immunoglobulin MAutoantibodies to Proteins Mimicking and Not Mimicking Epstein-Barr Virus Nuclear Antigen-I (2013) (0)
Antinuclear Factors in Rheumatoid Arthritis and Lupus Erythematosus. (1964) (0)
Brief Definitive Report in Vitro Effects of Epstein-barr Virus on Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Normal Subjects* (0)
Metabolic inhibition ofplaque-forming cells: comparison ofhumanrheumatoid-facto (2011) (0)
Letter: Correction: posterior interosseous nerve. (1973) (0)
EVALUATION OF A NEW VASOPRESSOR AGENT. ANGIOTENSIN AMIDE. (1963) (0)
Patent Number : 45 ) Date of Patent : 5 , 122 , 448 Jun . 16 , 1992 54 ASSAY OF ANTI-EPSTEIN-BARR VIRUS (2017) (0)
Continued Evolution of a Journal (1970) (0)
[Rheumatoid factor producing cells detected by direct hemolytic plaque assay (author's transl)]. (1977) (0)
The eighth (1961) interim scientific session of the American Rheumatism Association. (1962) (0)
Comment on Venables letter (1984) (0)
Cellular aspects of the immunology of rheumatoid arthritis. (1975) (0)
リウマトイド因子のantibody-dependent cell-mediated cytotoxicityへの影響 (1977) (0)
Immunochemical nature of anti red cell antibodies. (1958) (0)
Role of gamma globulin complexes in rheumatoid arthritis. (1968) (0)
Thirty years experience with radiation therapy of pharyngeal lymphoid tissue. (1956) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John H. Vaughan?

John H. Vaughan is affiliated with the following schools:

Columbia University